Introduction
============

*Staphylococcus aureus* is a major human pathogen capable of causing a wide range of infections, including skin and soft tissue infections, Healthcare-associated infections (nosocomial infections), food poisoning and life-threatening infections such as toxic shock syndrome, endocarditis, osteomyelitis, meningitis and pneumonia [@B01],[@B02].

The pathogenicity of *S. aureus* is very complex, involving numerous bacterial products and sophisticated regulatory pathways [@B03]. Many virulence factors have been described, such as antibiotic resistance, production of exotoxins and enzymes that contribute to its ability to colonize and cause disease [@B01],[@B04].

Some strains produce one or more exoproteins, including staphylococcal enterotoxins (SE), toxic shock syndrome toxin (TSST-1), exfoliative toxins (ET) and leukocidins [@B04].

Superantigenicity is one of the most studied properties of this exoproteins, which refers to its ability to activate 20 to 30% of T lymphocytes with a massive production of pro-inflammatory cytokines and chemokines that can cause fever, hypotension and other disorders including potentially lethal shock [@B01],[@B05],[@B06].

There are five known types of classical enterotoxins (SEA to SEE), many new types of enterotoxins have been described, called nonclassical enterotoxins (SEG to SEU) [@B01],[@B04],[@B07]-[@B10]and more recently described, superantigen SElX (*selx gene*), that contributes to the lethality of a strain CA-MRSA in necrotizing pneumonia (community acquired-Methicillin Resistant *S. aureus*) [@B11].

Most types of enterotoxins are encoded in mobile genetic elements located on pathogenicity islands, transposons, plasmids, phages or highly variable genetic regions (vSaβ) [@B06],[@B11]. There is an enterotoxin gene cluster (*egc*) that groups the genes *seg-sei-sem-seo-sen* and sometimes *seu*, which has been linked to increased virulence of *S. aureus*strains and is the most commonly detected. It is located in the pathogenicity island vSA [@B09],[@B12],[@B13]. Other genes of enterotoxins are detected in the methicillin resistance chromosomal cassette (*SCCmec*) [@B14].

Exfoliative toxins produced by *S. aureus* are responsible for the scalded skin syndrome (SSS), which causes the most sever bullous skin manifestations. It primarily affects infants and young children [@B15],[@B16]. ETs are classified as ETA, ETB, and ETD, ETA and ETB. ETB being the most frequent [@B17],[@B18]and ETD the less frequent [@B19].

Recent studies show the prevalence of superantigen genes in *S. aureus* isolates from different sources and geographical regions. Some clinical studies have attempted to correlate the results of detection of superantigen genes in patients with *S. aureus* infections, but their relationship has not been elucidated [@B05],[@B20],[@B21].

The objective of the study was to establish the relationship between the profile of superantigen genes (SEs, ETs and TSST-1) to antiobiotic resistance, to clinical specimen type (blood, secretions, others specimens), and to hospital (HA: Hospital-Acquired) or community (CA: Community-Acquired) in isolates of *S. aureus* in order to try to establish the potential virulence of hospital isolates.

Materials and Methods
=====================

A prospective study was carried out with 81 isolates obtained between February 2009 and March 2011. Only *S. aureus* isolates from patients with diagnosis of Healthcare-associated infections of both sex and adult were included and excluded patients with polymicrobial infections and children. We analyzed only the first isolation cultured by the clinical laboratory. The study was approved and supervised by the Bioethics Committee of the Faculty of Health Sciences - Technological University of Pereira.

The identification of clinical isolates and antibiotic susceptibility were performed by Automated Systems for Susceptibility Testing (WalkAway/Microscan^®^, Dade Behring) at clinical laboratory of the Hospital Universitario San Jorge (Pereira-Colombia), this hospital is an institution providing health services II, III and IV levels of care, with 402 hospital beds and an average monthly hospital admissions and discharge of 2,100 and 1,700 patients, respectively. The levels of care correspond to the therapies and services provided.

The isolates were confirmed as *S. aureus* by PCR using primers: Sa442-1 5\'-AAT CTT TGT CGG TAC ACG ATA TTC TTC ACG -3\' and Sa442-2 5\'-CGT AAT GAG ATT TCA GTA GAT AAT ACA ACA -3\', to amplify a portion of the species-specific gene Sa442 of *S. aureus* [@B22].

Classification of S. aureus isolates
------------------------------------

The isolates were classified according to the type of clinical specimen (blood, secretions, and others). Secretions which come from ears, eyes, muscle, burns, scalp, joint regions, osteosynthesis material, abscesses and wounds. Samples of devices such as catheters and tracheobronchial aspirates, pleural, peritoneal and cerebrospinal fluid and urine were classified as others. The isolates were also classified as resistance to one or more antibiotics and finally isolates were classified by the Hospital Universitario San Jorge as home hospital (HA) or community (CA).

DNA extraction
--------------

The CTAB (cetyltrimethylammonium bromide) genomic DNA extraction method was modified to use lysostaphin and the methodology described by Johnson *et al* [@B23]. The extracted DNA was stored at -20^°^ C in aliquots of 20 ng/μL for subsequent analysis by PCR

Identification of superantigen genes
------------------------------------

All isolates were examined for 22 genes (*sea to see, tsst-1, seg to ser, seu, eta, etb and etd)* by PCR. Five reference strains were used as positive controls, containing one or more superantigens genes: ATCC 700699, ATCC BAA-1707, ATCC 13565, ATCC 13566 and ATCC 19095 (FRI137).

The nucleotide sequences for all the primers used in this study and their respective amplification products are described for other authors [@B10],[@B18],[@B24] **(** [Table 1](#t01){ref-type="table"}).

Table 1.Primers, nucleotide sequence and the size of PCR amplification products.GenePrimer sequence (5´- 3´)Size (bp)Reference*sea*GGT TAT CAA TGT GCG GGT GG10224CGG CAC TTT TTT CTC TTC GG*seb*GTA TGG TGG TGT AAC TGA GC16424CCA AAT AGT GAC GAG TTA GG*sec*AGA TGA AGT AGT TGA TGT GTA TGG45124CAC ACT TTT AGA ATC AAC CG*sed*CCA ATA ATA GGA GAA AAT AAA AG27824ATT GGT ATT TTT TTT CGT TC*see*AGG TTT TTT CAC AGG TCA TCC20924CTT TTT TTT CTT CGG TCA ATC*tst*ACC CCT GTT CCC TTA TCA TC32624TTT TCA GTA TTT GTA ACG CC*eta*GCA GGT GTT GAT TTA GCA TT9324AGA TGT CCC TAT TTT TGC TG*etb*ACA AGC AAA AGA ATA CAG CG22624GTT TTT GGC TGC TTC TCT TG*etd*AAC TAT CAT GTA TCA AGG37618CAG AAT TTC CCG ACT CAG*seg*AAGTAGACATTTTTGGCGTTCC28725AGAACCATCAAACTCGTATAGC*seh*GTCTATATGGAGGTACAACACT21325GACCTTTACTTATTTCGCTGTC*sei*GGTGATATTGGTGTAGGTAAC45425ATCCATATTCTTTGCCTTTACCAG*sej*ATAGCATCAGAACTGTTGTTCCG15225CTTTCTGAATTTTACCACCAAAGG*sek*TAGGTGTCTCTAATAATGCCA29325TAGATATTCGTTAGTAGCTG*sel*TAACGGCGATGTAGGTCCAGG38325CATCTATTTCTTGTGCGGTAAC*sem*GGATAATTCGACAGTAACAG37925TCCTGCATTAAATCCAGAAC*sen*TATGTTAATGCTGAAGTAGAC28225ATTTCCAAAATACAGTCCATA*seo*TGTGTAAGAAGTCAAGTGTAG21425TCTTTAGAAATCGCTGATGA*sep*TGATTTATTAGTAGACCTTGG39625ATAACCAACCGAATCACCAG*seq*AATCTCTGGGTCAATGGTAAGC12225TTGTATTCGTTTTGTAGGTATTTTCG*ser*GGATAAAGCGGTAATAGCAG16625GTATTCCAAACACATCTAAC*seu*ATTTGCTTTTATCTTCAT16710GGACTTTAATGTTTGTTTCTGAT*fem A*AAAAAAGCACATAACAAGCG13224GATAAAGAAGAAACCAGCAG*fem B*TTACAGAGTTAACTGTTACC65125ATACAAATCCAGCACGCTCT

Multiplex PCR
-------------

Two sets of multiplex PCR were used to detect classical enterotoxins genes (*sea to see*), toxic shock syndrome toxin (*tsst-1*) and exfoliative toxins (*eta y etb*). The internal control of the reactions was a couple of primers femA, that amplified a 132 bp fragment of the *femA* gene (structural component of peptidoglycan, associated to methicillin resistance) [@B10],[@B18],[@B24]. Reference ATCC strains were used as positive controls and sterile distilled water as negative control.

Multiplex PCR series A included primers for genes *sea, seb, sec, sed, see and femA.* The amplification reaction was performed in a final volume of 25 µL, containing 1X buffer (50 mM KCl, 10 mM Tris-HCl, pH 9.0), 3 mM MgCl~2~, 200 µM dNTPs, 20 pmol each of the primers *sea, seb, sec and see,* 40 pmoles of primer *sed*, 1 U of Taq polymerase (Invitrogen) and 1 µL of DNA at a concentration of 20 ng/µL. Amplification was performed in a thermocycler (Perkin Elmer GeneAmp 9700), under the following conditions: denaturation at 94^º^ C for 1 min, annealing at 61^º^ C for 30 s and extension at 74^º^ C for 1 min, for 35 cycles [@B24].

Multiplex PCR series B included the primers for exfoliative toxins A and B genes and the toxic shock syndrome toxin (TSST-1). The amplification reaction had the same constituents and concentrations of the amplification reaction for the series A, except for the primer *eta* that must be 50 pmoles, as stated in Mehrotra *et al* [@B24]. For *tst-1* and *etb* is 20 pmoles. Amplification temperatures and cycles are as described for the set A.

Individual PCR (Uniplex)
------------------------

Was used to detect nonclassical enterotoxin genes: *seg to ser, seu,*and exfoliative toxin *etd*. Gene *FemB* primers were used as an internal control of the reactions, which is also an essential factor for the expression of methicillin resistance [@B25]. Reference ATCC strains were used as positive control and sterile distilled water negative control.

The reaction mixture (25 µL) consisted of 20 pmol of each primer, 2.5 mM MgCl~2~, 200 µM of each oligonucleotide, 1 U of Taq DNA polymerase and 1X buffer. Thermocycler conditions were: denaturation at 94^º^ C for 30 s, annealing at 55^º^ C for 30 s, and extension at 72^º^ C for 60 s for 30 cycles [@B25].

Detection and analysis of all the amplified products was performed by 2% agarose gel electrophoresis stained with ethidium bromide.

Statistical analysis
--------------------

Contingency tables were prepared and different correlations were analyzed between the presence or absence of superantigens genes against antimicrobial resistance, clinical specimen type, source of isolation of *S. aureus,*hospital or community acquired. Fisher\'s exact test was applied and *p*≤0.05 with a confidence interval of 95%, were considered statistically significant.

Results
=======

Eighty one isolates of *S. aureus*identified by Automated Systems for Susceptibility Testing and were confirmed by Sa442 gene amplification (100%). The distributions of isolates between genders were 48.1% (39/81) for male with an average of 6.2 genes detected and 51.9% (42/81) for female with an average of 4.9 genes. No statistically significant difference (*p*= 0.37).

Classification of S. aureus isolates according to the type clinical specimen
----------------------------------------------------------------------------

Clinical isolates of *S. aureus* were classified according to the type of clinical sample: 23 blood isolates (28.4%), 39 from secretions (48.1%) and 19 clinical specimens were classified as others (23.5%).

Antimicrobial susceptibility in S. aureus isolates
--------------------------------------------------

Antimicrobial susceptibility indicated that 6 isolates (7.4%) were susceptible to all 12 antimicrobial group´s (26 antimicrobials) tested and 75 (92.6%) were resistant to one or more antibiotics. The resistance range varied from 92.6% (75/81) for Beta- Lactam to 1.2% (1/81) to rifamycin. Additionally, 31 isolates was resistant for oxacillin (38.7%) phenotypically classified as MRSA isolates ([Table 2](#t02){ref-type="table"}).

Table 2.Antimicrobial group\'s susceptibility in *S. aureus* isolates. N= 81Antimicrobial groupS%R%Beta-Lactam67.475.092.6Chloranphenicol8110000.0Quinolones5466.727733.3Clindamycin5466.727733.3Macrolide4353.138146.9Fusidic acid8110000.0Aminoglycoside5669.125130.9Nitrofurantoin8110000.0Rifamycin8098.811.2Tetracycline5972.822827.2Trimethoprim/Sulfonamide8110000.0Glycopeptide8110000.0[^2][^3]

Prevalence and distribution of the genes encoding superantigens
---------------------------------------------------------------

The prevalence of the 22 genes detected by PCR in the 81 isolates of *S. aureus*was 95.1% (77/81) and in 4.9% (4/81) no genes were detected. The range of genes detected was at least 2 genes in 11 isolates (13.6%) and up to 13 genes in 6 isolates (7.5%), for an average of 5.9 genes.

The distribution of genes showed 39 genotypes and the genotype *gimnou* (complete *egc*cluster) was the most prevalent (16.0%) and associated with other genes (13.6%) followed by *sek-seq* with 18.4% and 42.0% of the genotypes had different combinations of genes.

The prevalence of individual genes was variable and *seg* was the most prevalent gene (51.9%), followed by *seq* (45.7%) and the lowest prevalence was *eta* (2.5%). No *sep, ser*or *etb* genes were detected. The difference was marked between classical enterotoxins with a gene average of 0.44 and with 4.0 for nonclassical genes ([Table 3](#t03){ref-type="table"}).

Table 3.Profile of superantigen genes distributed as classical, nonclassical, toxic shock syndrome toxin and exfoliative toxins in clinical isolates of *S. aureus*.VariablesGeneNP%Classical superantigenssea911.1seb89.9sec1316.0sed33.7see33.7Toxic shock syndrome toxintsst-156.2Nonclassical superantigensseg4251.9seh2935.8sei3644.4sej33.7sek2530.9sel1822.2sem2733.3sen3644.4seo3037.0seq3745.7seu4150.6Exfoliative toxineta22.5etd3442.0[^4]

Correlation between the presence of superantigen genes and antimicrobial susceptibility
---------------------------------------------------------------------------------------

In 6 antimicrobial susceptible isolates 6.2% (5/81) superantigen genes were detected and 1.2% had none. In resistant, 92.6% had them, in the latter case there were no resistant isolates without superantigens. No significant difference (*p*= 0.074) ([Table 4](#t04){ref-type="table"}).

Table 4.Relationship between superantigens genes with antimicrobial susceptibility, hospital or community origin and type of clinical sample.SuperantigensAntimicrobial susceptibilityAcquired placeType clinical specimenS%R%HA%CA%Blood%Secretion%Other%SAg+56.27592.63543.24251.92125.93745.71923.5SAg-11.200.044.900.022.522.500.0Total67.47592.63948.14251.92328.43948.11923.5p0.0740.0490.566[^5]

Beta-Lactam were the only group that showed statistically significant difference (*p* \<0.05) in the correlation between the superantigens genes and antimicrobial group\'s susceptibility in*S. aureus*isolates.

Correlation between the presence of superantigen genes and type of hospital and community isolate
-------------------------------------------------------------------------------------------------

[Table 4](#t04){ref-type="table"} shows the detection of superantigen genes according to the origin HA or CA, where 43.2% (35/81) isolates for HA had one or more SAg genes and 59.9% (42/81) of CA isolates had one or more superantigens genes of with statistically significant difference (*p*= 0.049).

Correlation between the presence of superantigen genes and the type of clinical sample
--------------------------------------------------------------------------------------

Of the 23 isolates from blood specimens, 21 (25.9%) had one or more genes with an average of 5.2 superantigen genes. For secretion, of the 39 isolates, 37 (45.7%) genes were detected with an average of 5.8 genes, and for the 19 isolates classified as other specimens, all genes were detected (23.5%) with an average of 6.9 genes. Statistical analysis by Fisher\'s exact test showed no significant difference (*p*= 0.566) ([Table 4](#t04){ref-type="table"}).

Discussion
==========

*Staphylococcus aureus* is the second most isolated pathogen from infections at the Hospital Universitario San Jorge de Pereira as well as in all the hospitals around Colombia [@B26]. 95.1% of all isolates contained at least one superantigen gene. High prevalence has also been reported by Varshney *et al*., 99% [@B05], Chiang *et al*., 91.8% [@B10], Xie *et al*., 90.7% [@B27] and Omoe *et al*., 77.4% [@B25].

The prevalence of individual genes varied as reported by other researchers [@B05],[@B06],[@B10]. The most common single gene in the study was*seg* (51.9%) which also has been reported by other studies [@B06],[@B10], [@B25]. In Colombia, Portillo *et al.* [@B28], found the *seg*gene at 94% in isolated MRSA.

For other genes, in contrast to Portillo, we detected *tsst, sea, seb, sec, seh* and *sel*but not *sep, ser*and*etb* genes, this indicates heterogeneity genetic of *S. aureus* intro the same country. This indicates that the presence of individual genes or associations between them is very diverse in all isolates of *S. aureus* regardless of origin.

The number of genotypes detected was 39, similar to that reported by Omoe *et al*. [@B25], and greater than that reported by Kuroda *et al*. [@B09], which allows us to infer that the number of genotypes is variable and dependent to the type of strain and the geographic area from which the isolate proceeded.

The presence of the full *egc* cluster or in coexistence with other SAgs in this study is consistent with other reports of its prevalence [@B05],[@B06],[@B12],[@B29]and lower than that reported by Portillo *et al*. [@B28], An interesting fact was the detection of the gene couple *sek-seq* (18.5%) associated with phage φ-3 followed in frequency the *egc* cluster; the couple *sed-sej* encoded on plasmid pIB485 reported by Varshney *et al*., was not found [@B05].

In this study no significant differences were established between the presence of superantigens and type of clinical specimen (blood, secretions, and others) and the same happened when compared with antimicrobial susceptibility. The only relationship that showed a significant difference was the comparison between the presence of superantigens against hospital (HA) or community (CA) origin.

Conclusions
===========

The high detection and the variety of arrangements of superantigen genes in hospital isolates of *S. aureus* demonstrate their virulence, and their presence allows differentiation between CA and HA isolates.

No correlation was established between superantigens and carry genes for antibiotic resistance or type of clinical specimen. In future studies it will be necessary to establish the importance of the *egc*cluster as a possible marker for virulence in *S. aureus* isolates.

It is important to note that one limitation of the study was unable to establish superantigen gene expression in vitro. The detection de superantigens proteins will be made in future research to determine the true virulence in hospital isolates of *S. aureus*.

Today, the analysis of the interplay between virulence, epidemic and antibiotic resistance of bacterial populations is needed to predict the future of infectious diseases.
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